Available On Demand
The pharmaceutical market in China has experienced tremendous growth over the past several decades and is becoming increasingly important. While many life sciences organizations consider China to be a ‘must win’ market, commercial success can be elusive. Despite the large patient base and recent economic and political tailwinds driving the advancement of the healthcare industry, sales for innovative drugs in China are often only a fraction of those in the U.S. The complex and rapidly evolving market dynamics require companies to stay on the cutting edge of new regulatory pathways, pricing/market access and go-to-market models.
Join Trinity Life Sciences’ APAC experts as they explore the key dynamics of the pharmaceutical market in China and uncover multiple strategies and levers that can elevate commercial success in this market.
Key Webinar Topics
- Regulatory pathways to accelerate commercial launch in China
- Balancing pros and cons
- Insights from recent launches
Complete the form below to view the on-demand webinar:
By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.